Extraintestinal Manifestations of Inflammatory Bowel Disease;Extraintestinale Manifestationen bei Chronisch-entzündlichen Darmerkrankungen

Medizinische Klinik

Volumn 99, Issue 3, 2004, Pages 123-130

  Rogler, Gerhard ^a   Schölmerich, Jürgen ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Crohn's disease'; Extraintestinal manifestations; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

CALCIUM; HLA B27 ANTIGEN; NEUTROPHIL CYTOPLASMIC ANTIBODY; RHEUMATOID FACTOR; VITAMIN D;

ADULT; AGED; ARTHRITIS; CHRONIC DISEASE; CROHN DISEASE; ENTERITIS; FEMALE; GRANULOMATOUS INFLAMMATION; HUMAN; IDIOPATHIC OSTEOPOROSIS; MAJOR CLINICAL STUDY; MALE; PRIMARY SCLEROSING CHOLANGITIS; QUALITY OF LIFE; REVIEW; SKIN INFLAMMATION; SYMPTOMATOLOGY; ULCERATIVE COLITIS; VITAMIN DEFICIENCY;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFLAMMATION; QUALITY OF LIFE;

EID: 1642299563     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-004-1003-2     Document Type: Review

References (185)

1. Acker SM, Sahn EE, Rogers HC, et al. Genital cutaneous Crohn disease: two cases with unusual clinical and histopathologic features in young men. Am J Dermatopathol 2000;22:443-6.
2. Adam DJ, Nawroz I, Petrie PW. Pyoderma gangrenosum severely affecting both hands. J Hand Surg [Br] 1996;21:792-4.
3. Ahmad I, Owens D. Granulomatous cheilitis and Crohn's disease. Can J Gastroenterol 2001;15:273-5.
4. Altman AR, Maltz C, Janowitz HD. Autoimmune hemolytic anemia in ulcerative colitis: report of three cases, review of the literature, and evaluation of modes of therapy. Dig Dis Sci 1979;24:282-5.
5. Apgar JT. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review. Semin Dermatol 1991;10:138-47.
6. Arner O, Brohult J, Engstedt L, et al. Autoimmune hemolytic anemia in ulcerative colitis, cured by colectomy. Report of a case. Acta Med Scand 1971;189:275-7.
7. Bachmeyer C, Leclerc-Landgraf N, Laurette F, et al. Acute autoimmune sensorineural hearingloss associated with Crohn's disease. Am J Gastroenterol 1998;93:2565-7.
8. Bar-Dayan Y, Ben-Zikrie S, Fraser G, et al, Pulmonary alveolar hemorrhage in a patient with ulcerative colitis and primary sclerosing cholangitis. Isr Med Assoc J 2002;4:464-5.
9. Basista MH, Roe DC. A case presentation of hemolytic anemia in ulcerative colitis and review of the literature. Am J Gastroenterol 1986;81:990-2.
10. Bernstein CN. Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep 2001;3:477-83.
11. Bernstein CN, Blanchard JF, Rawsthorne P, et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001;96:1116-22.
12. Bewig B, Manske I, Bottcher H, et al. Crohn's disease mimicking sarcoidosis in bronchoalveolar lavage. Respiration 1999;66:467-9.
13. Bijmer-Iest JC, Rompelman-Schiere SI, Van Ginkel CJ. Treatment of pyoderma gangrenosum with cyclosporin. Br J Dermatol 1991;125:283.
14. Bonner GF. Using COX-2 inhibitors in IBD: anti-inflammatories inflame a controversy. Am J Gastroenterol 2002;97;783-5.
15. Bozkurt T, Langer M, Fendel K, et al. Granulomatous tonsillitis. A rare extraintestinal manifestation of Crohn's disease. Dig Dis Sci 1992;37:1127-30.
16. Brohee P, Violon P, Mavroudakis N, et al. Central nervous system lesions associated with Crohn's disease. J Neuroimaging 1997;7:195-8.
17. Broome U, Glaumann H, Hellers G, et al. Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm. Gut 1994;35:84-9.
18. Broome U, Lindberg G, Lofberg R, Primary sclerosing cholangitis in ulcerative colitis - a risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology 1992;102:1877-80.
19. Broome U, Lofberg R, Veress B, et al. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995;22:1404-8.
20. Buckles DC, Lindor KD, Larusso NF, et al. In primary sclerosing cholangitis, gallbladder polyps are frequently malignant. Am J Gastroenterol 2002;97:1138-42.
21. Callen JP. Acute febrile neutrophilic dermatosis (Sweet's syndrome) and the related conditions of "bowel bypass" syndrome and bullous pyoderma gangrenosum. Dermatol Clin 1985;3:153-63.
22. Callen JP. Pyoderma gangrenosum and related disorders. Adv Dermatol 1989;4:51-65.
23. Cardinali C, Giomi B, Caproni M, et al. Guess what! Malignant pyoderma responding to cyclosporine. Eur J Dermatol 2001;11:595-6.
24. Carp JM, Onuma E, Das K, et al. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease. Cutis 1997;60:135-8.
25. Castellvi Suana JM, Perello Juan A, Cervantes Amau X, et al. Autoimmune hemolytic anemia, infrequent complication of ulcerative colitis. Rev Esp Enferm Dig 1994;86:908-11.
26. Chad DA, Smith TW, DeGirolami U, et al. Perineuritis and ulcerative colitis. Neurology 1986;36:1377-9.
27. Chapman RW. The management of primary sclerosing cholangitis. Curr Gastroenterol Rep 2003;5:9-17.
28. Chiba M, Iizuka M, Horie Y, et al. Metastatic Crohn's disease involving the penis. J Gastroenterol 1997;32:817-21.
29. Chiba M, Nakajima K, Arakawa H, et al. Anti-erythrocyte antibodies in ulcerative colitis: case report and discussion on the pathophysiology of anti-erythrocyte antibody. Gastroenterol Jpn 1988;23:564-9.
30. Christodoulou DK, Katsanos KH, Kitsanou M, et al. Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature. Dig Liver Dis 2002;34:781-6.
31. Cipolla G, Crema F, Sacco S, et al. Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives. Pharmacol Res 2002;46:1-6.
32. Clements D, Carter C, Allan RN. Autoimmune haemolytic anaemia complicating ulcerative colitis. Br J Hosp Med 1988;40:72.
33. Coenen C, Borsch G, Muller KM, et al. Oral inflammatory changes as an initial manifestation of Crohn's disease antedating abdominal diagnosis. Report of a case. Dis Colon Rectum 1988;31:548-52.
34. Collazzo JA, Siddiqui MA, Deren JJ. Concomitant onset of ulcerative colitis and autoimmune hemolytic anemia in an 83-yr-old woman. Am J Gastroenterol 1996;91:2236-7.
35. Cummins RE, Mullins D, Smith LJ, et al. Metastatic Crohn's disease: a case report. Pediatr Dermatol 1996;13:25-8.
36. Curley RK, Macfarlane AW, Vickers CF. Pyoderma gangrenosum treated with cyclosporin A. Br J Dermatol 1985;113:601-4.
37. Danzi JT. Extraintestinal manifestations of idiopathic inflammatory bowel disease. Arch Intern Med 1988;148:297-302.
38. D'Arienzo A, Manguso F, Scarpa R, et al. Ulcerative colitis, seronegative spondyloarthropathies and allergic diseases: the search for a link. Scand J Gastroenterol 2002;37:1156-63.
39. D'Inca R, Fagiuoli S, Stumiolo GC. Tacrolimus to treat pyoderma gangrenosum resistant to cyclosporine. Ann Intern Med 1998;128:783-4.
40. Edwards JC, Bowness P, Archer JR. Jekyll and Hyde: the transformation of HLA-B27. Immunol Today 2000;21:256-60.
41. Eilam O, Goldin E, Shouval D, et al. Sclerosing cholangitis associated with Crohn's disease and autoimmune haemolytic anaemia. Postgrad Med J 1993;69:656-8.
42. Esber EJ, Ferguson DR. Primary sclerosing cholangitis. Gastroenterologist 1994;2:131-46.
43. Feliciani C, Tulli A. Topical cyclosporin in the treatment of dermatologic diseases. Int J Immunopathol Pharmacol 2002;15:89-93.
44. Fellermann K, Rudolph B, Witthoft T, et al. Sweet syndrome and erythema nodosum in ulcerative colitis, refractory to steroids: successful treatment with tacrolimus. Med Klin 2001;96:105-8.
45. Fireman Z, Osipov A, Kivity S, et al. The use of induced sputum in the assessment of pulmonary involvement in Crohn's disease. Am J Gastroenterol 2000;95:730-4,
46. Freeman HJ, Freeman KJ. Prevalence rates and an evaluation of reported risk factors for osteonecrosis (avascular necrosis) in Crohn's disease. Can J Gastroenterol 2000;14:138-43.
47. Friedman S, Marion JF, Scherl E, et al. Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease. Inflamm Bowel Dis 2001;7:1-7.
48. Futami H, Kodaira M, Furuta T, et al. Pyoderma gangrenosum complicating ulcerative colitis: successful treatment with methylprednisolone pulse therapy and cyclosporine. J Gastroenterol 1998;33:408-11.
49. Geissler A, Andus T, Poth M, et al. Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet 1995;345:897-8.
50. Generini S, Fiori G, Matucci Cerinic M. Therapy of spondylarthropathy in inflammatory bowel disease. Clin Exp Rheumatol 2002;20:S88-94.
51. Giannadaki E, Potamianos S, Roussomoustakaki M, et al. Autoimmune hemolytic anemia and positive Coombs test associated with ulcerative colitis. Am J Gastroenterol 1997;92:1872-4.
52. Gilger MA, Gann ME, Opekun AR, et al. Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children. J Pediatr Gastroenterol Nutr 2000;31:136-41.
53. Gionchetti P, Schiavina M, Campieri M, et al. Bronchopulmonary involvement in ulcerative colitis. J Clin Gastroenterol 1990;12:647-50.
54. Girlich C, Bogenrieder T, Palitzsch KD, et al. Orofacial granulomatosis as initial manifestation of Crohn's disease: a report of two cases. Eur J Gastroenterol Hepatol 2002;14:873-6.
55. Glanz S, Maceyko RF, Camisa C, et al. Mucocutaneous presentations of Crohn's disease. Cutis 1991;47:167-72.
56. Goldstone AH. Autoimmune haemolytic anaemia in ulcerative colitis. Br Med J 1974;2:556.
57. Gorst DW, Leyland MJ, Delamore IW. Autoimmune haemolytic anaemia and ulcerative colitis. Postgrad Med J 1975;51:409-11.
58. Goudet P, Dozois RR, Kelly KA, et al. Characteristics and evolution of extraintestinal manifestations associated with ulcerative colitis after proctocolectomy. Dig Surg 2001;18:51-5.
59. Gow JG. An appraisal of inflammatory structures of the ureter. Ann R Coll Surg Engl 1972;51:177-89.
60. Gran JT, Husby G. Joint manifestations in gastrointestinal diseases. 1. Pathophysiological aspects, ulcerative colitis and Crohn's disease. Dig Dis 1992;10:274-94.
61. Grandval P, Barthet M, Desjeux A, et al. Pseudotumorous chronic pancreatitis associated with inflammatory bowel disease. Dig Dis Sci 2001;46:898-900.
62. Gravallese EM, Kantrowitz FG. Arthritic manifestations of inflammatory bowel disease. Am J Gastroenterol 1988;83:703-9.
63. Greenstein AJ, Janowitz HD, Sachar DB. The extraintestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976;55:401-12.
64. Groisser DS, Griffiths CE, Ellis CN, et al. A review and update of the clinical uses of cyclosporine in dermatology. Dermatol Clin 1991;9:805-17.
65. Gumaste V, Greenstein AJ, Meyers R, et al. Coombs-positive autoimmune hemolytic anemia in ulcerative colitis. Dig Dis Sci 1989;34:1457-61.
66. Habeeb MA, Rajalingam R, Dhar A, et al. HLA association and occurrence of autoantibodies in Asian-Indian patients with ulcerative colitis. Am J Gastroenterol 1997;92:772-6,
67. Hamois DM, Angulo P, Jorgensen RA, et al. High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis. Am J Gastroenterol 2001;96:1558-62.
68. Heinrich R, Riedel L, Schomerus H. Bronchopulmonary infiltrates in chronic inflammatory bowel disease. Dtsch Med Wochenschr 1983;108:1106-10.
69. Hernandez F, Linares M, Ferrer L, et al. Auto-immune haemolytic anaemia in ulcerative colitis: report of three cases. Acta Haematol 1994;91:213-4.
70. Herrlinger KR, Stange EF. The pancreas and inflammatory bowel diseases. Int J Pancreatol 2000;27:171-9.
71. Heuer DK, Gager WE, Reeser FH. Ischemic optic neuropathy associated with Crohn's disease. J Clin Neuroophthalmol 1982;2:175-81.
72. Hochman JA. Autoimmune hemolytic anemia associated with Crohn's disease. Inflamm Bowel Dis 2002;8:98-100.
73. Hofley P, Roarty J, McGinnity G, et al. Asymptomatic uveitis in children with chronic inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 1993;17:397-400.
74. Holm T, Kildahl-Andersen O, Valle PC. Primary sclerosing cholangitis with autoimmune hemolytic anemia and pulmonary infiltrations. Scand J Gastroenterol 1998;33:669-72.
75. Holtmeier J, Leuschner U. Medical treatment of primary biliary cirrhosis and primary sclerosing cholanitis. Digestion 2001;64:137-50.
76. Humbert P, Monnier G, Billerey C, et al. Polyneuropathy: an unusual extraintestinal manifestation of Crohn's disease. Acta Neurol Scand 1989;80:301-6.
77. James DG. Multi-system ocular syndromes. J R Coll Physicians Lond 1974;9:63-78.
78. Kafity AA, Pellegrini AE, Fromkes JJ. Metastatic Crohn's disease. A rare cutaneous manifestation. J Clin Gastroenterol 1993;17:300-3.
79. Kaufmann HJ, Taubin HL. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med 1987;107:513-6.
80. Kettering JM, Towers JD, Rubin DA. The seronegative spondyloarthropathies. Semin Roentgenol 1996;31:220-8.
81. Khan MA. HLA-B27 and B12(B44) in Crohn's disease with ankylosing spondylitis. J Rheumatol 1989;16:851-2.
82. Ko CB, Walton S, Wyatt EH. Pyoderma gangrenosum: associations revisited. Int J Dermatol 1992;31:574-7.
83. Konagaya Y, Konagaya M, Takayanagi T. Chronic polyneuropathy and ulcerative colitis. Jpn J Med 1989;28:72-4.
84. Kriskovich MD, Kelly SM, Jackson WD. Nasal septal perforation: a rare extraintestinal manifestation of Crohn's disease. Ear Nose Throat J 2000;79:520-3.
85. Kuzela L, Vavrecka A, Prikazska M, et al. Pulmonary complications in patients with inflammatory bowel disease. Hepatogastroenterology 1999;46:1714-9.
86. Lamers CB. Treatment of extraintestinal complications of ulcerative colitis. Eur J Gastroenterol Hepatol 1997;9:850-3.
87. Lang B, Weber S, Maas D. Autoimmune hemolytic anemia in ulcerative colitis. Report on 7 cases, possible treatment and review of the literature. Schweiz Med Wochenschr 1985;115:897-902.
88. Lapinski TW, Puzanowska B, Ziarko S. Prevalence of HLA class I and II antigens and extra-bowel manifestations in ulcerative colitis. Pol Merkuriusz Lek 2002;13:133-6.
89. Larrode P, Ramon YCS, Iniguez C, et al. Peripheral neuropathy associated with intestinal inflammatory disease. Neurologia 2001;16:133-7.
90. Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid-mechanisms of action and clinical use in hepatobiliary disorders. J Hepatol 2001;35:134-46.
91. Leidenius MH, Koskimies SA, Kellokumpu IH, et al. HLA antigens in ulcerative colitis and primary sclerosing cholangitis. APMIS 1995;103:519-24.
92. Levitt MD, Ritchie JK, Lennard-Jones JE, et al. Pyoderma gangrenosum in inflammatory bowel disease. Br J Surg 1991;78:676-8.
93. Lewicki LJ, Leeson MJ. The multisystem impact on physiologic processes of inflammatory bowel disease. Nurs Clin North Am 1984;19:71-80.
94. Lim KK, Su WP, Schroeter AL, et al. Cyclosporine in the treatment of dermatologic disease: an update. Mayo Clin Proc 1996;71:1182-91.
95. Lindberg BU, Broome U, Persson B. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study. Dis Colon Rectum 2001;44:77-85.
96. Lindgren S, Lilja B, Rosen I, et al. Disturbed autonomic nerve function in patients with Crohn's disease. Scand J Gastroenterol 1991;26:361-6.
97. Lindgren S, Stewenius J, Sjolund K, et al. Autonomic vagal nerve dysfunction in patients with ulcerative colitis. Scand J Gastroenterol 1993;28:638-42.
98. Mahadeva R, Walsh G, Flower CD, et al. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J 2000;15:41-8.
99. Marchesa P, Lashner BA, Lavery IC, et al. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1997;92:1285-8.
100. Marshall JK, Irvine EJ. Successful therapy of refractory erythema nodosum associated with Crohn's disease using potassium iodide. Can J Gastroenterol 1997;11:501-2.
101. Matis WL, Ellis CN, Griffiths CE, et al. Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol 1992;128:1060-4.
102. McCartney SA, Mitchell JA, Fairclough PD, et al. Selective COX-2 inhibitors and human inflammatory bowel disease. Aliment Pharmacol Ther 1999;13:1115-7.
103. Mearin F, Moreno-Otero R, Rodriguez S, et al. Ulcerative colitis, autoimmune hemolytic anemia and rectovaginal fistula: report of a case. Arq Gastroenterol 1983;20:108-11.
104. Michel S, Hohenleutner U, Mohr V, et al. Therapy-resistant pyoderma gangrenosum - treatment with mycophenolate mofetil and cyclosporine A. Hautarzt 1999;50:428-31.
105. Misra SP, Singh SK, Chari ST, et al. Pyoderma gangrenosum in ulcerative colitis. J Assoc Physicians India 1991;39:570-1.
106. Mitchell SA, Bansi DS, Hunt N, et al. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology 2001;121:900-7.
107. Modena V, Amoroso A, Frattasio C, et al. HLA antigens and clinical manifestations in Crohn's disease. Clin Exp Rheumatol 1988;6:221-5.
108. Moller P, Vinje O, Berg K. HLA antigens, psoriasis and acute anterior uveitis in Bechterew's syndrome (ankylosing spondylitis). Clin Genet 1982;21:215-21.
109. Murphy PT, Cunney R, Nolan A, et al. Autoimmune haemolytic anaemia associated with ulcerative colitis. Ir Med J 1996;89:172-3.
110. Nasr IS. Topical tacrolimus in dermatology. Clin Exp Dermatol 2000;25:250-4.
111. Nuako KW, Ahlquist DA, Sandborn WJ, et al. Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis: a case-control study. Cancer 1998;82:822-6.
112. Okiyama R, Yamada M, Tamaki M, et al. Mononeuropathy multiplex with ulcerative colitis. Intern Med 1993;32:651-4.
113. Okolicsanyi L, Fabris L, Viaggi S, et al. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. Eur J Gastroenterol Hepatol 1996;8:685-91.
114. Orchard TR, Chua CN, Ahmad T, et al. Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology 2002;123:714-8.
115. Orchard TR, Jewell DP. The importance of ileocaecal integrity in the arthritic complications of Crohn's disease. Inflamm Bowel Dis 1999;5:92-7.
116. Orchard TR, Thiyagaraja S, Welsh KI, et al. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 2000;118:274-8.
117. Palm O, Moum B, Ongre A, et al. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol 2002;29:511-5.
118. Passo MH, Fitzgerald JF, Brandt KD. Arthritis associated with inflammatory bowel disease in children. Relationship of joint disease to activity and severity of bowel lesion. Dig Dis Sci 1986;31:492-7.
119. Penmetcha M, Navaratnam AE. Pyoderma gangrenosum. Response to cyclosporin A. Int J Dermatol 1988;27:253.
120. Petering H, Kiehl P, Breuer C, et al. Pyoderma gangrenosum: successful topical therapy with tacrolimus (FK506). Hautarzt 2001;52:47-50.
121. Petermann A, Tebbe B, Distler A, et al. Sweet's syndrome in a patient with acute Crohn's colitis and longstanding ankylosing spondylitis. Clin Exp Rheumatol 1999;17:607-10.
122. Petrelli EA, McKinley M, Troncale FJ. Ocular manifestations of inflammatory bowel disease. Ann Ophthalmol 1982;14:356-60.
123. Phillips SS, Baird DB, Joshi VV, et al. Crohn's disease of the prepuce in a 12-year-old boy: a case report and review of the literature. Pediatr Pathol Lab Med 1997;17:497-502.
124. Poulsen LO, Freund L, Lylloff K, et al. Positive Coombs' test associated with ulcerative colitis. A prevalence study. Acta Med Scand 1988;223:75-8.
125. Powell FC, Schroeter AL, Su WP, et al. Pyoderma gangrenosum: a review of 86 patients. Q J Med 1985;55:173-86.
126. Power WJ, Rodriguez A, Pedroza-Seres M, et al. Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology 1998;105:1646-51.
127. Ramakrishna R, Manoharan A. Auto-immune haemolytic anaemia in ulcerative colitis. Acta Haematol 1994;91:99-102.
128. Rampton DS, Sladen GE. Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs. Postgrad Med J 1981;57:297-9.
129. Ramzan NN, Leighton JA, Heigh RI, et al. Clinical significance of granuloma in Crohn's disease. Inflamm Bowel Dis 2002;8:168-73.
130. Rankin GB. Extraintestinal and systemic manifestations of inflammatory bowel disease. Med Clin North Am 1990;74:39-50.
131. Rankin GB, Watts HD, Melnyk CS, et al. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 1979;77:914-20.
132. Rappaport A, Shaked M, Landau M, et al. Sweet's syndrome in association with Crohn's disease: report of a case and review of the literature. Dis Colon Rectum 2001;44:1526-9.
133. Rath HC, Andus T, Caesar I, et al. Initial symptoms, extra-intestinal manifestations and course of pregnancy in chronic inflammatory bowel diseases. Med Klin 1998;93:395-400.
134. Raya Munoz J, Diez Ruiz A, Bonetti A, et al. Ulcerative colitis associated with autoimmune hemolytic anemia, arterial thrombosis and dermal necrosis. Rev Esp Enferm Apar Dig 1983;64:435-40.
135. Read AE. Pyoderma gangrenosum. Q J Med 1985;55:99-101.
136. Saegesser F. Urogenital complications of Crohn's disease. Helv Chir Acta 1980;46:727-30.
137. Saisho H. Pseudotumorous pancreatitis as an extraintestinal manifestation of ulcerative colitis: another member of so called "autoimmune pancreatitis"? Intern Med 2001;40:1172-3.
138. Salmon JF, Wright JP, Murray AD. Ocular inflammation in Crohn's disease. Ophthalmology 1991;98:480-4.
139. Scherbaum WA, Kaufmann R, Vogel U, et al. Henoch-Schönlein purpura with ileitis terminalis. Clin Investig 1993;71:564-7.
140. Schofer H, Baur S. Successful treatment of postoperative pyoderma gangrenosum with cyclosporin. J Eur Acad DermatoI Venereol 2002;16:148-51.
141. Schölmerich J, Hoppe-Seyler PGerok W. Extrain-testinale Manifestationen bei entzündlichen Darmerkrankungen. Therapiewoche 1986;36:520-32.
142. Schorr-Lesnick B, Brandt LJ. Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease. Am J Gastroenterol 1988;83:216-23.
143. Shad JA, Sharieff GQ. Tracheobronchitis as an initial presentation of ulcerative colitis. J Clin Gastroenterol 2001;33:161-3.
144. Shapiro SC, Rothstein FC, Newman AJ, et al. Multifocal osteonecrosis in adolescents with Crohn's disease: a complication of therapy? J Pediatr Gastroenterol Nutr 1985;4:502-6.
145. Shashaty GG. Hemolytic anemia and ulcerative colitis. Dig Dis Sci 1980;25:154-5.
146. Shashaty GG, Rath CE, Britt EJ. Autoimmune hemolytic anemia associated with ulcerative colitis. Am J Hematol 1977;3:199-208.
147. Shetty K, Rybicki L, Brzezinski A, et al. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1999;94:1643-9.
148. Simoneaux SF, Patrick LE. Genitourinary complications of Crohn's disease in pediatric patients. AJR Am J Poentgenol 1997;169:197-9.
149. Slaney G, Muller S, Clay J, et al. Crohn's disease involving the penis. Gut 1986;27:329-33.
150. Snook JA, de Silva HJ, Jewell DP. The association of antoimmune disorders with inflammatory bowel disease. Q J Med 1989;72:835-40.
151. Soria C, Allegue F, Martin M, et al. Treatment of pyoderma gangrenosum with cyclosporin A. Clin Exp Dermatol 1991;16:392-4.
152. Stange EF, Riemann J, Herbay A von, et al. Diagnosis and therapy of ulcerative colitis - results of an evidence-based consensus conference of the German Society of Digestive and Metabolic Diseases. Z Gastroenterol 2001;39:19-20.
153. Stange EF, Schreiber S, Folsch UR, et al. Diagnostics and treatment of Crohn's disease. Z Gastroenterol 2003;41:19-20.
154. Stiehl A, Benz CSauer P. Primary sclerosing cholangitis. Can J Gastroenterol 2000;14:311-5.
155. Stiehl A, Rudolph G, Sauer P, et al. Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol 1997;26:560-6.
156. Stiles RG, Carpenter WA, Tigges S. Osteonecrosis of the femoral heads in inflammatory bowel disease. N Engl J Med 1994;330:791; author reply:792.
157. Suh CH, Lee CH, Lee J, et al. Arthritic manifestations of inflammatory bowel disease. J Korean Med Sci 1998;13:39-43.
158. Tan MH, Gordon M, Lebwohl O, et al. Improvement of pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody. Arch Dermatol 2001;137:930-3.
159. Theissen U, Luger TA, Schwarz T. Successful topical administration of cyclosporin A in pyoderma gangraenosum. Hautarzt 1996;47:132-5.
160. Tiwana H, Wilson C, Walmsley RS, et al. Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis. Rheumatol Int 1997;17:11-6.
161. Travis S, Innes N, Davies MG, et al. Sweet's syndrome: an unusual cutaneous feature of Crohn's disease or ulcerative colitis. The South West Gastroenterology Group. Eur J Gastroenterol Hepatol 1997;9:715-20.
162. Triantafillidis JK, Cheracakis P, Sklavaina M, et al. Favorable response to infliximab treatment in a patient with active Crohn disease and pyoderma gangrenosum. Scand J Gastroenterol 2002;37:863-5.
163. Tromm A, May D, Almus E, et al. Cutaneous manifestations in inflammatory bowel disease. Z Gastroenterol 2001;39:137-44.
164. Turktas I, Bostanci I, Altuntas B. Rapidly progressive bronchiectasis complicating ulcerative colitis in a child. Turk J Pediatr 2001;43:151-4.
165. Van de Scheur MR, van der Waal RI, van Bodegraven AA, et al. Cheilitis granulomatosa and optic neuropathy as rare extraintestinal manifestations of Crohn's disease. J Clin Gastroenterol 2002;34:557-9.
166. Van Esser JW, Bos LP, Erdkamp FL. An uncommon cause of anaemia in ulcerative colitis. Neth J Med 1995;47:18-20.
167. Van Hoogstraten HJ, Vleggaar FP, Boland GJ, et al. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group. Am J Gastroenterol 2000;95:2015-22.
168. Van Steenbergen W, Fevery J, Vandenbrande P, et al. Ulcerative colitis, primary sclerosing cholangitis, bile duct carcinoma, and generalized sarcoidosis. Report of a unique association. J Clin Gastroenterol 1987;9:574-9.
169. Vaz A, Kramer K, Kalish RA. Sweet's syndrome in association with Crohn's disease. Postgrad Med J 2000;76:713-4.
170. Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 1996;23:29-34.
171. Veloso FT, Fraga J, Carvalho J, et al. Autoimmune hemolytic anemia in ulcerative colitis. A case report with review of the literature. J Clin Gastroenterol 1991;13:445-7.
172. V'Lckova-Laskoska MT, Laskoski DS, Caca-Biljanovska NG, et al. Pyoderma gangrenosum successfully treated with cyclosporin A. Adv Exp Med Biol 1999;455:541-5.
173. Von den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol 1997;137:1000-5.
174. Wagtmans MJ, Verspaget HW, Lamers CB, et al. Gender-related differences in the clinical course of Crohn's disease. Am J Gastroenterol 2001;96:1541-6.
175. Wang LH, Tsai MJ, Huang MT, et al. Autoimmune manifestations in patients with primary immunodeficiency. Acta Paediatr Taiwan 1999;40:243-9.
176. Wehrheim W. Crohn's disease simulating tuberculous ureteritis. Int Urol Nephrol 1973;5:359-62.
177. Wijesurendra CS, Singh G, Manuel AR, et al. Balanoposthitis - an unusual feature of Crohn's disease? Int J STD AIDS 1993;4:184.
178. Wilcox P, Miller R, Miller G, et al. Airway involvement in ulcerative colitis. Chest 1987;92:18-22.
179. Williams N, Scott NA, Watson JS, et al. Surgical management of perineal and metastatic cutaneous Crohn's disease. Br J Surg 1993;80:1596-8.
180. Williams SM, Harned RK. Hepatobiliary complications of inflammatory bowel disease. Radiol Clin North Am 1987;25:175-88.
181. Wodzinski MA, Lawrence AC. Severe Coombs positive autoimmune haemolytic anaemia associated with ulcerative colitis. Postgrad Med J 1985;61:261-2.
182. Wollina U. Clinical management of pyoderma gangrenosum. Am J Clin Dermatol 2002;3:149-58.
183. Yang J, Maronian N, Reyes V, et al. Laryngeal and other otolaryngologic manifestations of Crohn's disease. J Voice 2002;16:278-82.
184. Zincone A, Bogliun G, Crespi V, et al. Autonomic neuropathy in ulcerative colitis. Scand J Gastroenterol 1995;30:399-400.
185. Zlatanic J, Korelitz BI, Wisch N, et al. Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation? Am J Gastroenterol 1997;92:2285-8.